-20℃ 3 years powder
-80℃ 2 years in solvent
Ilorasertib hydrochloride (ABT-348 hydrochloride) is an ATP-competitive multitargeted kinase inhibitor, which inhibits Aurora C, Aurora B, and Aurora A (IC50s: 1 nM, 7 nM, 120 nM). It also suppresses RET tyrosine kinase, PDGFRβ, and Flt1 (IC50s: 7 nM, 3 nM, and 32 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | inquiry | 82.00 | |
5 mg | inquiry | 160.00 | |
10 mg | inquiry | 258.00 | |
50 mg | inquiry | 932.00 | |
100 mg | inquiry | 1567.00 | |
200 mg | inquiry | inquiry | |
500 mg | inquiry | inquiry | |
1 mL * 10 mM (in DMSO) | inquiry | 184.00 |
Description | Ilorasertib hydrochloride (ABT-348 hydrochloride) is an ATP-competitive multitargeted kinase inhibitor, which inhibits Aurora C, Aurora B, and Aurora A (IC50s: 1 nM, 7 nM, 120 nM). It also suppresses RET tyrosine kinase, PDGFRβ, and Flt1 (IC50s: 7 nM, 3 nM, and 32 nM). |
Targets&IC50 | Aurora C :ic50 1 nM, Aurora B :ic50 7 nM, Aurora B (Y156H) :ic50 12 nM, Aurora A :ic50 120 nM, PDGFRα :ic50 11 nM, PDGFRβ :ic50 13 nM, VEGFR1 :ic50 1 nM, VEGFR2 :ic50 2 nM, VEGFR3 :ic50 43 nM, FLT3 :ic50 1 nM, CSF-1R :ic50 3 nM, c-KIT :ic50 20 nM, |
Synonyms | ABT-348 hydrochloride |
Purity | 98.00% |
Molecular Weight | 525 |
Formula | C25H22ClFN6O2S |
CAS No. | 1847485-91-9 |
-20℃ 3 years powder
-80℃ 2 years in solvent
DMSO: 41.67 mg/mL (79.37 mM), Need ultrasonic
( < 1 mg/ml refers to the product slightly soluble or insoluble )
Safe and effective drug dosing is necessary, regardless of its purpose of administration. Learn More
bottom
Answers to questions you may have can be found in the Inhibitor Handling Instructions. Topics include how to prepare stock solutions, how to store Products, and issues that need special attention for cell-based assays and animal experiments.